A26-year-old man presents with a hard, painless testicular mass. At operation, frozen section reveals testicular cancer. Which of the following is a risk factor?
What serum marker can be used to monitor therapy?
- carcinoembryonic antigen (CEA)
- human chorionic gonadotropin (hCG)
- sedimentation rate
- lactic dehydrogenase (LDH)
- prostate-specific antigen (PSA)
Answer(s): B
Explanation:
Testicular cancer is the most common cancer in men between the ages of 20 and 40. Predisposing factors include cryptorchidism, hernias, and testicular atrophy. Abdominal testes are at higher risk than inguinal cryptorchid testes. Family history of testicular or prostate cancer, radiation exposure, or maternal DES seems to play no role. Testicular cancers are divided into nonseminoma and seminoma subtypes.
Seminoma represents about 50% of all tumors and generally follows a more indolent course. The primary tumor is treated by inguinal orchiectomy regardless of cell type. Pure seminomas do not require retroperitoneal lymph node dissection, because radiation is usually adequate therapy. Nonseminomatous testicular tumors (embryonal cell, teratocarcinoma, choriocarcinoma, endodermal sinus) are usually treated by retroperitoneal dissection. Serum alpha-fetoprotein (AFP) and hCG levels are markers that are important for diagnosis and as prognostic indicators and are used to monitor therapy. Serum LDH level is often elevated with bulky tumors but is not as specific as either AFP or hCG. CEA is a nonspecific marker elaborated by many adenocarcinomas. PSA is a marker associated with prostate cancer
Reveal Solution Next Question